Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. Curcumin - Wikipedia
Curcumin - Wikipedia
From Wikipedia, the free encyclopedia
Principal curcuminoid of turmeric
Not to be confused with Curculin.

Curcumin
Skeletal formula
Enol form
Skeletal formula
Keto form
Ball-and-stick model
Ball-and-stick model
Names
Pronunciation /ˈkɜːrkjʊmɪn/
Preferred IUPAC name
(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
Other names
  • (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
  • Diferuloylmethane
  • Curcumin I
  • C.I. 75300
  • Natural Yellow 3
Identifiers
CAS Number
  • 458-37-7 checkY
3D model (JSmol)
  • Interactive image
ChEBI
  • CHEBI:3962 checkY
ChEMBL
  • ChEMBL116438 ☒N
ChemSpider
  • 839564 checkY
ECHA InfoCard 100.006.619 Edit this at Wikidata
E number E100 (colours)
IUPHAR/BPS
  • 7000
KEGG
  • C10443
PubChem CID
  • 969516
UNII
  • IT942ZTH98 checkY
CompTox Dashboard (EPA)
  • DTXSID8031077 Edit this at Wikidata
InChI
  • InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+ checkY
    Key: VFLDPWHFBUODDF-FCXRPNKRSA-N checkY
  • InChI=1/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+
    Key: VFLDPWHFBUODDF-FCXRPNKRBF
SMILES
  • O=C(\C=C\c1ccc(O)c(OC)c1)CC(=O)\C=C\c2cc(OC)c(O)cc2
Properties
Chemical formula
C21H20O6
Molar mass 368.385 g·mol−1
Appearance Bright yellow-orange powder
Melting point 183 °C (361 °F; 456 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references
Chemical compound

Curcumin is a bright yellow chemical produced by plants of the Curcuma longa species. It is the principal curcuminoid of turmeric (Curcuma longa), a member of the ginger family, Zingiberaceae. It is sold as an herbal supplement, cosmetics ingredient, food flavoring, and food coloring.[1]

Chemically, curcumin is a polyphenol, more particularly a diarylheptanoid, belonging to the group of curcuminoids, which are phenolic pigments responsible for the yellow color of turmeric.[2]

Extensive studies have consistently failed to show any medical value for curcumin. It is difficult to study because it is both unstable and poorly bioavailable. It is unlikely to produce useful leads for drug development as a lead compound.[3]

History

[edit]

Curcumin was named in 1815 when Henri Auguste Vogel and Pierre Joseph Pelletier reported the first isolation of a "yellow coloring-matter" from the rhizomes of turmeric.[4] Later, it was found to be a mixture of resin and turmeric oil. In 1910, Milobedzka and Lampe reported the chemical structure of curcumin to be as diferuloylmethane.[5] Later in 1913, the same group accomplished the synthesis of the compound.

Although used in traditional medicine, the possible therapeutic properties of turmeric or curcumin remain undetermined.[3][6][7]

Uses

[edit]
Curcumin powder

The most common applications are as an ingredient in dietary supplement, in cosmetics, as flavoring for foods, such as turmeric-flavored beverages in South and Southeast Asia,[1] and as coloring for foods, such as curry powders, mustards, butters, and cheeses. As a food additive for orange-yellow coloring in prepared foods, its E number is E 100 in the European Union.[8][9] It is also approved by the U.S. FDA to be used as a food coloring in US.[10]

Chemistry

[edit]
A bright red substance in a small glass flask, held by gloved fingers
Curcumin becomes bright red when it interacts electrostatically with a phospholipid film

Curcumin incorporates a seven carbon linker and three major functional groups: an α,β-unsaturated β-diketone moiety and an aromatic O-methoxy-phenolic group.[2][5] The aromatic ring systems, which are phenols, are connected by two α,β-unsaturated carbonyl groups.[2][11] It is a diketone tautomer, existing in enolic form in organic solvents and in keto form in water.[12] The diketones form stable enols and are readily deprotonated to form enolates, which bind metal ions to form acetylacetonate-like complexes.[13] Its complexing properties are manifesting in its reaction with boric acid to give a red-colored rosocyanine.[2][14]

Because of its hydrophobic nature, curcumin is poorly soluble in water[2] but is easily soluble in organic solvents.[5]

Biosynthesis

[edit]

The biosynthetic route of curcumin is uncertain. In 1973, Peter J. Roughley and Donald A. Whiting proposed two mechanisms for curcumin biosynthesis. The first mechanism involves a chain extension reaction by cinnamic acid and 5 malonyl-CoA molecules that eventually arylize into a curcuminoid. The second mechanism involves two cinnamate units coupled together by malonyl-CoA. Both use cinnamic acid as their starting point, which is derived from the amino acid phenylalanine.[15]

Plant biosynthesis starting with cinnamic acid is rare compared to the more common p-coumaric acid.[15] Only a few identified compounds, such as anigorufone and pinosylvin, build from cinnamic acid.[16][17]

Curcumin biosynthesis diagram
Biosynthetic pathway of curcumin in Curcuma longa.[15]

Pharmacology

[edit]
Curcumin displays green fluorescence under UV light

Curcumin, which shows positive results in most drug discovery assays, is regarded as a false lead that medicinal chemists include among "pan-assay interference compounds". This attracts undue experimental attention while failing to advance as viable therapeutic or drug leads,[3][6][18] although some derivatives of curcumin such as EF-24 have been well-studied.[19]

Factors that limit the bioactivity of curcumin or its analogs include chemical instability, water insolubility, absence of potent and selective target activity, low bioavailability, limited tissue distribution, and extensive metabolism.[3] Very little curcumin escapes the GI tract and most is excreted in feces unchanged.[20] If curcumin enters plasma in reasonable amounts, there is a high risk of toxicity since it is promiscuous, and interacts with several proteins known to increase the risk of adverse effects, including hERG, cytochrome P450s, and glutathione S-transferase.[3]

Safety

[edit]

Although curcumin has been assessed in numerous laboratory and clinical studies, it has no medical uses.[21] Its instability, reactivity, and poor bioavailability, make curcumin an unlikely drug candidate.[3] Curcumin exhibits numerous interference properties which may lead to misinterpretation of results.[3][6][22]

Between 1995 and 2017, the US government funded US$150 million in biomedical research into curcumin through the National Center for Complementary and Integrative Health. No support was found for curcumin as a medical treatment.[3] As a component of turmeric, curcumin may interact with prescription drugs and dietary supplements.[23] In high amounts, it may be unsafe for women during pregnancy.[23] It may cause side effects, such as nausea, diarrhea, hives, or dizziness.[23] Between 2004 and 2022 there were ten cases of liver injury caused by curcumin herbal and dietary supplements.[24] Curcumin is a contact allergen.[25]

The intended use of curcumin as a food additive is generally recognized as safe by the U.S. Food and Drug Administration.[26]

Research fraud

[edit]

Bharat Aggarwal, a former cancer researcher at the University of Texas MD Anderson Cancer Center, had 29 papers retracted due to research fraud as of July 2021[update].[27][28][29] Aggarwal's research had focused on potential anti-cancer properties of herbs and spices, particularly curcumin, and according to a March 2016 article in the Houston Chronicle, "attracted national media interest and laid the groundwork for ongoing clinical trials".[30][31][32]

Aggarwal cofounded a company in 2004 called Curry Pharmaceuticals based in Research Triangle Park, North Carolina, which planned to develop drugs based on synthetic analogs of curcumin.[31][33] SignPath Pharma, a company seeking to develop liposomal formulations of curcumin, licensed three patents by Aggarwal related to that approach from MD Anderson in 2013.[34]

Warnings about dietary supplements

[edit]

Between 2018 and 2023, the U.S. FDA issued 29 warning letters to American manufacturers of dietary supplements for making false claims of anti-disease effects from using products containing curcumin.[35] In each letter, the FDA stated that the supplement product was not an approved new drug because the "product is not generally recognized as safe and effective" for the advertised uses, that "new drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from FDA", and that the "FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective".[35]

Alternative medicine

[edit]

Though there is no evidence for the safety or efficacy of using curcumin as a therapy,[3][6] some alternative medicine practitioners give it intravenously, supposedly as a treatment for numerous diseases.[36][37][38] In 2017, two serious cases of adverse events were reported from curcumin or turmeric products—one severe allergic reaction and one death[36]—that were caused by administration of a curcumin-polyethylene glycol (PEG40) emulsion product by a naturopath.[38] One treatment caused anaphylaxis leading to death.[36][38]

Stability

[edit]

In 2016, laboratory research established and compared the radiosensitivity of three organic food colorants including curcumin, carmine, and annatto to create data to be used for application whenever food products containing these food colors were to undergo the radiation process.[39] The researchers used spectrophotometry and capillary electrophoresis to establish radiosensitivity of the three organic food colorants. Carmine samples were quite stable against radiation treatment, annatto showed limited stability, and curcumin was found to be unstable, particularly when diluted.[39]

References

[edit]
  1. ^ a b Majeed S (28 December 2015). "The State of the Curcumin Market". Natural Products Insider. Archived from the original on October 17, 2017. Retrieved February 29, 2016.
  2. ^ a b c d e CID 969516 from PubChem
  3. ^ a b c d e f g h i Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA (March 2017). "The Essential Medicinal Chemistry of Curcumin". Journal of Medicinal Chemistry. 60 (5): 1620–1637. doi:10.1021/acs.jmedchem.6b00975. PMC 5346970. PMID 28074653.
    See also: Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA (May 2017). "Curcumin May (Not) Defy Science". ACS Medicinal Chemistry Letters. 8 (5): 467–470. doi:10.1021/acsmedchemlett.7b00139. PMC 5430405. PMID 28523093.
  4. ^ Vogel, A; Pelletier, J (July 1815). "Examen chimique de la racine de Curcuma" [Chemical examination of turmeric root]. Journal de Pharmacie et des Sciences Accessoires (in French). 1: 289–300. available at Gallica.
  5. ^ a b c Farooqui, Tahira; Farooqui, Akhlaq A. (2019). "Curcumin: Historical Background, Chemistry, Pharmacological Action, and Potential Therapeutic Value". Curcumin for Neurological and Psychiatric Disorders. pp. 23–44. doi:10.1016/B978-0-12-815461-8.00002-5. ISBN 978-0-12-815461-8. S2CID 146070671.
  6. ^ a b c d Baker M (January 2017). "Deceptive curcumin offers cautionary tale for chemists". Nature. 541 (7636): 144–145. Bibcode:2017Natur.541..144B. doi:10.1038/541144a. PMID 28079090.
  7. ^ "Turmeric". US National Center for Complementary and Integrative Health, National Institutes of Health. April 2020. Retrieved 24 October 2023.
  8. ^ European Commission. "Food Additives". Archived from the original on October 8, 2022. Retrieved February 15, 2014.
  9. ^ "Curcumin, E 100, page 9". Specifications for food additives listed in Annexes II and III to Regulation (EC) No 1333/2008 of the European Parliament. March 9, 2012. Retrieved July 24, 2019.
  10. ^ "CFR – Code of Federal Regulations Title 21". www.accessdata.fda.gov.
  11. ^ Miłobȩdzka J, van Kostanecki S, Lampe V (1910). "Zur Kenntnis des Curcumins" [Knowing about curcumin]. Berichte der Deutschen Chemischen Gesellschaft (in German). 43 (2): 2163–2170. doi:10.1002/cber.191004302168.
  12. ^ Manolova Y, Deneva V, Antonov L, Drakalska E, Momekova D, Lambov N (November 2014). "The effect of the water on the curcumin tautomerism: a quantitative approach" (PDF). Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 132: 815–820. Bibcode:2014AcSpA.132..815M. doi:10.1016/j.saa.2014.05.096. PMID 24973669.
  13. ^ Pham, Chien Thang; Pham, Thu Thuy; Nguyen, Hung Huy; Trieu, Thi Nguyet (2020). "Syntheses, Structures, and Bioactivities Evaluation of some Transition Metal Complexes with 4,4'-Diacetylcurcumin". Zeitschrift für Anorganische und Allgemeine Chemie. 646 (11–12): 495–499. Bibcode:2020ZAACh.646..495P. doi:10.1002/zaac.202000088.
  14. ^ National Exposure Research Laboratory (EPA-NERL) (1974). "EPA-NERL: 212.3: Boron by Colorimetry – Boron (Colorimetric, Curcumin)". National Environmental Methods Index. Archived from the original on 2017-02-03. Retrieved 2024-02-18.
  15. ^ a b c Kita T, Imai S, Sawada H, Kumagai H, Seto H (July 2008). "The biosynthetic pathway of curcuminoid in turmeric (Curcuma longa) as revealed by 13C-labeled precursors". Bioscience, Biotechnology, and Biochemistry. 72 (7): 1789–1798. doi:10.1271/bbb.80075. PMID 18603793.
  16. ^ Schmitt B, Hölscher D, Schneider B (February 2000). "Variability of phenylpropanoid precursors in the biosynthesis of phenylphenalenones in Anigozanthos preissii". Phytochemistry. 53 (3): 331–337. Bibcode:2000PChem..53..331S. doi:10.1016/S0031-9422(99)00544-0. PMID 10703053.
  17. ^ Gehlert R, Schoeppner A, Kindl H (1990). "Stilbene Synthase from Seedlings of Pinus sylvestris: Purification and Induction in Response to Fungal Infection" (PDF). Molecular Plant-Microbe Interactions. 3 (6): 444–449. Bibcode:1990MPMI....3..444G. doi:10.1094/MPMI-3-444.
  18. ^ Bisson J, McAlpine JB, Friesen JB, Chen SN, Graham J, Pauli GF (March 2016). "Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?". Journal of Medicinal Chemistry. 59 (5): 1671–1690. doi:10.1021/acs.jmedchem.5b01009. PMC 4791574. PMID 26505758.
  19. ^ He, Yonghan; Li, Wen; Hu, Guangrong; Sun, Hui; Kong, Qingpeng (11 December 2018). "Bioactivities of EF24, a Novel Curcumin Analog: A Review". Frontiers in Oncology. 8 614. doi:10.3389/fonc.2018.00614. PMC 6297553. PMID 30619754.
  20. ^ Metzler M, Pfeiffer E, Schulz SI, Dempe JS (2013). "Curcumin uptake and metabolism". BioFactors. 39 (1): 14–20. doi:10.1002/biof.1042. PMID 22996406. S2CID 8763463.
  21. ^ "Curcumin". Micronutrient Information Center; Phytochemicals. Linus Pauling Institute, Oregon State University, Corvallis. 2016. Retrieved June 18, 2016.
  22. ^ Lowe, Derek (12 January 2017). "Curcumin Will Waste Your Time". Science Blogs.
  23. ^ a b c "Turmeric". Drugs.com. December 6, 2017. Retrieved November 28, 2018.
  24. ^ Halegoua-DeMarzio, Dina; Navarro, Victor; Ahmad, Jawad; Avula, Bharathi; Barnhart, Huiman; Barritt, A. Sidney; Bonkovsky, Herbert L.; Fontana, Robert J.; Ghabril, Marwan S.; Hoofnagle, Jay H.; Khan, Ikhlas A.; Kleiner, David E.; Phillips, Elizabeth; Stolz, Andrew; Vuppalanchi, Raj (2023). "Liver Injury Associated with Turmeric—A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]". The American Journal of Medicine. 136 (2). Elsevier BV: 200–206. doi:10.1016/j.amjmed.2022.09.026. ISSN 0002-9343. PMC 9892270. PMID 36252717.
  25. ^ Chaudhari SP, Tam AY, Barr JA (November 2015). "Curcumin: A Contact Allergen". J Clin Aesthet Dermatol. 8 (11): 43–48. PMC 4689497. PMID 26705440.
  26. ^ "GRAS Notice (GRN) No. 822". U.S. Food & Drug Administration. GRAS Notice Inventory. Archived from the original on December 3, 2020.
  27. ^ "The Retraction Watch Leaderboard". Retraction Watch. 16 June 2015. Retrieved 28 July 2021.
  28. ^ Ackerman T (February 29, 2012). "M.D. Anderson professor under fraud probe". Houston Chronicle. Retrieved March 8, 2016.
  29. ^ "Caught Our Notice: Researcher who once threatened to sue Retraction Watch now up to 19 retractions". Retraction Watch. April 10, 2018.
  30. ^ Ackerman T (March 2, 2016). "M.D. Anderson scientist, accused of manipulating data, retires". Houston Chronicle.
  31. ^ a b Stix G (February 2007). "Spice Healer". Scientific American. 296 (2): 66–69. Bibcode:2007SciAm.296b..66S. doi:10.1038/scientificamerican0207-66. PMID 17367023.
  32. ^ Ackerman T (July 11, 2005). "In cancer fight, a spice brings hope to the table". Houston Chronicle. Retrieved March 24, 2015.
  33. ^ Singh S (September 2007). "From exotic spice to modern drug?". Cell. 130 (5): 765–768. doi:10.1016/j.cell.2007.08.024. PMID 17803897. S2CID 16044143.
  34. ^ Baum S (March 26, 2013). "Biotech startup raises $1M for lung cancer treatment using component of tumeric". Med City News.
  35. ^ a b "Warning Letters: Curcumin (search term)". US Food and Drug Administration. 23 April 2023. Archived from the original on April 28, 2019. Retrieved 23 April 2023.
  36. ^ a b c "FDA investigates two serious adverse events associated with ImprimisRx's compounded curcumin emulsion product for injection". Food and Drug Administration. August 4, 2017. Archived from the original on November 2, 2017.
  37. ^ Hermes BM (March 27, 2017). "Naturopathic Doctors Look Bad After California Woman Dies From Turmeric Injection". Forbes. Retrieved May 12, 2017.
  38. ^ a b c Hermes BM (April 10, 2017). "Confirmed: Licensed Naturopathic Doctor Gave Lethal 'Turmeric' Injection". Forbes. Retrieved December 9, 2017.
  39. ^ a b Cosentino, Helio M.; Takinami, Patricia Y.I.; del Mastro, Nelida L. (2016). "Comparison of the ionizing radiation effects on cochineal, annatto and turmeric natural dyes". Radiation Physics and Chemistry. 124: 208–211. Bibcode:2016RaPC..124..208C. doi:10.1016/j.radphyschem.2015.09.016.

External links

[edit]
  • Curcumin (Curcuma, Turmeric) and Cancer (PDQ®)–Health Professional Version
  • Medicines containing turmeric or curcumin, risk of liver injury, Safety advisory
  • First draft statement on the potential risk to human health of turmeric and curcumin
  • v
  • t
  • e
Curcuminoids
  • 1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one
  • Bisdemethoxycurcumin
  • Curcumin
  • Desmethoxycurcumin
  • Dimethylcurcumin
Curcuminoid dyes
  • Rosocyanine
  • Rubrocurcumin
  • v
  • t
  • e
Histone deacetylase inhibitors
  • 3,3'-Diindolylmethane
  • β-Hydroxybutyric acid (β-hydroxybutyrate)
  • Abexinostat
  • Acetoacetic acid (acetoacetate)
  • Allyl mercaptan
  • Apicidin
  • Belinostat
  • Butyric acid (butyrate)
  • Capsaicin
  • Citarinostat
  • Curcumin
  • Diallyl disulfide
  • Entinostat
  • Fimepinostat
  • Givinostat
  • Ifupinostat
  • Indole-3-carbinol
  • Kevetrin
  • Martinostat
  • Mocetinostat
  • Niacinamide
  • Panobinostat
  • Parthenolide
  • Phenylbutyrate
  • Pracinostat
  • Quisinostat
  • Resminostat
  • Romidepsin
  • Scriptaid
  • Sodium butyrate
  • Sodium oxybate (GHB sodium)
  • Sodium phenylbutyrate
  • Sodium valproate
  • Sulforaphane
  • Trapoxin B
  • Trichostatin A
  • Tucidinostat
  • Valnoctamide
  • Valproic acid (valproate)
  • Valproate pivoxil
  • Valproate semisodium
  • Valpromide
  • Vorinostat (SAHA)
See also: Receptor/signaling modulators
  • v
  • t
  • e
Leukotriene signaling modulators
Receptor
(ligands)
BLTTooltip Leukotriene B4 receptor
BLT1Tooltip Leukotriene B4 receptor 1
  • Agonists: 12-HETE
  • 20-Hydroxy-LTB4
  • Leukotriene B4
  • LY-255283
  • Antagonists: 20-Carboxy-LTB4
  • Amelubant
  • CGS-23131 (LY-223982)
  • CGS-25019C
  • CP-105696
  • CP-195543
  • Etalocib
  • LY-293111
  • Moxilubant
  • ONO-4057
  • RG-14893
  • RP-69698
  • SB-209247
  • SC-53228
  • Ticolubant
  • U-75302
  • ZK-158252
BLT2Tooltip Leukotriene B4 receptor 2
  • Agonists: 12-HETE
  • 12-HHT
  • 12-HpETE
  • 15-HETE
  • 15-HpETE
  • 20-Hydroxy-LTB4
  • Leukotriene B4
  • Antagonists: CP-195543
  • LY-255283
  • ZK-158252
CysLTTooltip Cysteinyl leukotriene receptor
CysLT1Tooltip Cysteinyl leukotriene receptor 1
  • Agonists: Leukotriene C4
  • Leukotriene D4
  • Leukotriene E4
  • Antagonists: Ablukast
  • BAYu9773
  • BAYu9916
  • BAYx7195
  • Cinalukast
  • FPL-55712
  • ICI-198615
  • Iralukast
  • LY-170680
  • Masilukast
  • MK-571
  • Montelukast
  • ONO-1078
  • Pobilukast
  • Pranlukast
  • Ritolukast
  • SKF-104353
  • SR-2640
  • Sulukast
  • Tipelukast
  • Tomelukast
  • Verlukast
  • Zafirlukast
  • ZD-3523
  • Gemilukast
  • Quinotolast
CysLT2Tooltip Cysteinyl leukotriene receptor 2
  • Agonists: Leukotriene C4
  • Leukotriene D4
  • Leukotriene E4
  • Antagonists: BAYu9773
  • BAYu9916
CysLTETooltip Cysteinyl leukotriene receptor E
  • Agonists: Leukotriene E4
Enzyme
(inhibitors)
5-LOXTooltip Arachidonate 5-lipoxygenase
  • 2-TEDC
  • Baicalein
  • BW-A4C
  • BW-B70C
  • Caffeic acid
  • CDC
  • CJ-13610
  • Curcumin
  • Fenleuton
  • Hyperforin
  • Hypericum perforatum (St. John's Wort)
  • Meclofenamic acid (meclofenamate)
  • Minocycline
  • N-Stearoyldopamine
  • Timegadine
  • Zileuton
  • FLAPTooltip Arachidonate 5-lipoxygenase-activating protein inhibitors: AM-103
  • AM-679
  • BAYx1005
  • MK-591
  • MK-886
12-LOXTooltip Arachidonate 12-lipoxygenase
  • 2-TEDC
  • 3-Methoxytropolone
  • Baicalein
  • CDC
15-LOXTooltip Arachidonate 15-lipoxygenase
  • 2-TEDC
  • CDC
  • KNX-100 (SOC-1)
  • Luteolin
  • PD-146176
LTA4HTooltip Leukotriene A4 hydrolase
  • Acebilustat
  • Captopril
  • DG-051
  • Fosinoprilat
  • JNJ-26993135
  • SA-6541
  • SC-57461A
  • Ubenimex (bestatin)
LTB4HTooltip Leukotriene B4 ω-hydroxylase
  • 17-Octadecynoic acid
LTC4STooltip Leukotriene C4 synthase
  • Azelastine
  • MK-886
LTC4HTooltip Leukotriene C4 hydrolase
  • Acivicin
  • Serine-borate complex
LTD4Tooltip Leukotriene D4 hydrolase
  • Cilastatin
  • Ubenimex (bestatin)
Others
  • Precursors: Linoleic acid
  • γ-Linolenic acid (gamolenic acid)
  • Dihomo-γ-linolenic acid
  • Diacylglycerol
  • Arachidonic acid
  • 5-HPETE (arachidonic acid 5-hydroperoxide)
  • Leukotriene A4
See also
Receptor/signaling modulators
Prostanoid signaling modulators
  • v
  • t
  • e
Prostanoid signaling modulators
Receptor
(ligands)
DP (D2)Tooltip Prostaglandin D2 receptor
DP1Tooltip Prostaglandin D2 receptor 1
  • Agonists: Prostaglandin D2
  • Treprostinil
  • Antagonists: Asapiprant
  • Laropiprant
  • Vidupiprant
DP2Tooltip Prostaglandin D2 receptor 2
  • Agonists: Indometacin
  • Prostaglandin D2
  • Antagonists: ADC-3680
  • AZD-1981
  • Bay U3405
  • Fevipiprant
  • MK-1029
  • MK-7246
  • QAV-680
  • Ramatroban
  • Setipiprant
  • Timapiprant
  • TM30089
  • Vidupiprant
EP (E2)Tooltip Prostaglandin E2 receptor
EP1Tooltip Prostaglandin EP1 receptor
  • Agonists: Beraprost
  • Enprostil
  • Iloprost (ciloprost)
  • Latanoprost
  • Lubiprostone
  • Misoprostol
  • Prostaglandin E1 (alprostadil)
  • Prostaglandin E2 (dinoprostone)
  • Sulprostone
  • Antagonists: AH-6809
  • ONO-8130
  • SC-19220
  • SC-51089
  • SC-51322
EP2Tooltip Prostaglandin EP2 receptor
  • Agonists: Butaprost
  • Misoprostol
  • Prostaglandin E1 (alprostadil)
  • Prostaglandin E2 (dinoprostone)
  • Treprostinil
  • Antagonists: AH-6809
  • PF-04418948
  • TG 4-155
EP3Tooltip Prostaglandin EP3 receptor
  • Agonists: Beraprost
  • Carbacyclin
  • Cicaprost
  • Enprostil
  • Iloprost (ciloprost)
  • Isocarbacyclin
  • Latanoprost
  • Misoprostol
  • Prostaglandin D2
  • Prostaglandin E1 (alprostadil)
  • Prostaglandin E2 (dinoprostone)
  • Remiprostol
  • Ricinoleic acid
  • Sulprostone
  • Antagonists: L-798106
EP4Tooltip Prostaglandin EP4 receptor
  • Agonists: Lubiprostone
  • Misoprostol
  • Prostaglandin E1 (alprostadil)
  • Prostaglandin E2 (dinoprostone)
  • TCS-2510
  • Antagonists: Grapiprant
  • GW-627368
  • L-161982
  • ONO-AE3-208
Unsorted
  • Agonists: 16,16-Dimethyl Prostaglandin E2
  • Aganepag
  • Carboprost
  • Evatanepag
  • Gemeprost
  • Nocloprost
  • Omidenepag
  • Prostaglandin F2α (dinoprost)
  • Simenepag
  • Taprenepag
FP (F2α)Tooltip Prostaglandin F receptor
  • Agonists: Alfaprostol
  • Bimatoprost
  • Carboprost
  • Cloprostenol
  • Enprostil
  • Fluprostenol
  • Latanoprost
  • Prostaglandin D2
  • Prostaglandin F2α (dinoprost)
  • Sulotroban
  • Tafluprost
  • Travoprost
  • Unoprostone
IP (I2)Tooltip Prostacyclin receptor
  • Agonists: ACT-333679
  • AFP-07
  • Beraprost
  • BMY-45778
  • Carbacyclin
  • Cicaprost
  • Iloprost (ciloprost)
  • Isocarbacyclin
  • MRE-269
  • NS-304
  • Prostacyclin (prostaglandin I2, epoprostenol)
  • Prostaglandin E1 (alprostadil)
  • Ralinepag
  • Selexipag
  • Taprostene
  • TRA-418
  • Treprostinil
  • Antagonists: RO1138452
TP (TXA2)Tooltip Thromboxane receptor
  • Agonists: Carbocyclic thromboxane A2
  • I-BOP
  • Thromboxane A2
  • U-46619
  • Vapiprost
  • Antagonists: 12-HETE
  • 13-APA
  • AA-2414
  • Argatroban
  • Bay U3405
  • BMS-180,291
  • Daltroban
  • Domitroban
  • EP-045
  • GR-32191
  • ICI-185282
  • ICI-192605
  • Ifetroban
  • Imitrodast
  • L-655240
  • L-670596
  • Linotroban
  • Mipitroban
  • ONO-3708
  • ONO-11120
  • Picotamide
  • Pinane thromboxane A2
  • Ramatroban
  • Ridogrel
  • S-145
  • Samixogrel
  • Seratrodast
  • SQ-28,668
  • SQ-29,548
  • Sulotroban
  • Terbogrel
  • Terutroban
  • TRA-418
Unsorted
  • Arbaprostil
  • Ataprost
  • Ciprostene
  • Clinprost
  • Cobiprostone
  • Delprostenate
  • Deprostil
  • Dimoxaprost
  • Doxaprost
  • Ecraprost
  • Eganoprost
  • Enisoprost
  • Eptaloprost
  • Esuberaprost
  • Etiproston
  • Fenprostalene
  • Flunoprost
  • Froxiprost
  • Lanproston
  • Limaprost
  • Luprostiol
  • Meteneprost
  • Mexiprostil
  • Naxaprostene
  • Nileprost
  • Nocloprost
  • Ornoprostil
  • Oxoprostol
  • Penprostene
  • Pimilprost
  • Piriprost
  • Posaraprost
  • Prostalene
  • Rioprostil
  • Rivenprost
  • Rosaprostol
  • Spiriprostil
  • Tiaprost
  • Tilsuprost
  • Tiprostanide
  • Trimoprostil
  • Viprostol
Enzyme
(inhibitors)
COX
(PTGS)
  • Salicylic acids: Aloxiprin
  • Aspirin (acetylsalicylic acid)
  • Benorilate (benorylate)
  • Carbasalate calcium
  • Diflunisal
  • Dipyrocetyl
  • Ethenzamide
  • Guacetisal
  • Magnesium salicylate
  • Mesalazine (5-aminosalicylic acid)
  • Methyl salicylate
  • Salacetamide
  • Salicin
  • Salicylamide
  • Salicylate (salicylic acid)
  • Salsalate
  • Sodium salicylate
  • Triflusal; Acetic acids: Aceclofenac
  • Acemetacin
  • Aclofenac
  • Amfenac
  • Alclofenac
  • Bendazac
  • Bromfenac
  • Bufexamac
  • Bumadizone
  • Cinmetacin
  • Clometacin
  • Diclofenac
  • Difenpiramide
  • Etodolac
  • Felbinac
  • Fenclofenac
  • Fentiazac
  • Glucametacin
  • Indometacin (indomethacin)
  • Indometacin farnesil
  • Ketorolac
  • Lonazolac
  • Mofezolac
  • Nabumetone
  • Oxametacin
  • Oxindanac
  • Proglumetacin
  • Sulindac
  • Sulindac sulfide
  • Tolmetin
  • Zidometacin
  • Zomepirac; Propionic acids: Alminoprofen
  • Benoxaprofen
  • Bucloxic acid (blucloxate)
  • Butibufen
  • Carprofen
  • Dexibuprofen
  • Dexindoprofen
  • Dexketoprofen
  • Fenbufen
  • Fenoprofen
  • Flunoxaprofen
  • Flurbiprofen
  • Ibuprofen
  • Ibuproxam
  • Indoprofen
  • Ketoprofen
  • Loxoprofen
  • Miroprofen
  • Naproxen
  • Naproxcinod
  • Oxaprozin
  • Pirprofen
  • Pranoprofen
  • Suprofen
  • Tarenflurbil
  • Tepoxalin
  • Tiaprofenic acid (tiaprofenate)
  • Vedaprofen; Anthranilic acids (fenamic acids): Etofenamic acid (etofenamate)
  • Floctafenic acid (floctafenate)
  • Flufenamic acid (flufenamate)
  • Meclofenamic acid (meclofenamate)
  • Mefenamic acid (mefenamate)
  • Morniflumic acid (morniflumate)
  • Niflumic acid (niflumate)
  • Talinflumic acid (talinflumate)
  • Tolfenamic acid (tolfenamate); Pyrazolones: Azapropazone
  • Dipyrone
  • Isopyrin
  • Oxyphenbutazone
  • Phenylbutazone; Enolic acids (oxicams): Ampiroxicam
  • Droxicam
  • Enolicam
  • Isoxicam
  • Lornoxicam
  • Meloxicam
  • Piroxicam
  • Tenoxicam; 4-Aminoquinolines: Antrafenine
  • Floctafenine
  • Glafenine; Quinazolines: Fluproquazone
  • Proquazone; Aminonicotinic acids: Clonixeril
  • Clonixin
  • Flunixin; Sulfonanilides: Flosulide
  • Nimesulide; Aminophenols (anilines): Acetanilide
  • AM-404 (N-arachidonoylaminophenol)
  • Bucetin
  • Paracetamol (acetaminophen)
  • Parapropamol
  • Phenacetin
  • Propacetamol; Selective COX-2 inhibitors (coxibs): Apricoxib
  • Celecoxib
  • Cimicoxib
  • Deracoxib
  • Etoricoxib
  • Firocoxib
  • Lumiracoxib
  • Mavacoxib
  • Parecoxib
  • Polmacoxib
  • Robenacoxib
  • Rofecoxib
  • Tilmacoxib
  • Valdecoxib; Others/unsorted: Anitrazafen
  • Clobuzarit
  • Curcumin
  • DuP-697
  • FK-3311
  • Flumizole
  • FR-122047
  • Glimepiride
  • Hyperforin
  • Itazigrel
  • L-655240
  • L-670596
  • Licofelone
  • Menatetrenone (vitamin K2)
  • NCX-466
  • NCX-4040
  • NS-398
  • Pamicogrel
  • Resveratrol
  • Romazarit
  • Rosmarinic acid
  • Rutecarpine
  • Satigrel
  • SC-236
  • SC-560
  • SC-58125
  • Tenidap
  • Tiflamizole
  • Timegadine
  • Trifenagrel
  • Tropesin
PGD2STooltip Prostaglandin D synthase
  • Retinoids
  • Selenium (selenium tetrachloride, sodium selenite, selenium disulfide)
PGESTooltip Prostaglandin E synthase
HQL-79
PGFSTooltip Prostaglandin F synthase
Bimatoprost
PGI2STooltip Prostacyclin synthase
Tranylcypromine
TXASTooltip Thromboxane A synthase
  • Camonagrel
  • Dazmegrel
  • Dazoxiben
  • Furegrelate
  • Isbogrel
  • Midazogrel
  • Nafagrel
  • Nicogrelate
  • Ozagrel
  • Picotamide
  • Pirmagrel
  • Ridogrel
  • Rolafagrel
  • Samixogrel
  • Terbogrel
  • U63557A
Others
  • Precursors: Linoleic acid
  • γ-Linolenic acid (gamolenic acid)
  • Dihomo-γ-linolenic acid
  • Diacylglycerol
  • Arachidonic acid
  • Prostaglandin G2
  • Prostaglandin H2
See also
Receptor/signaling modulators
Leukotriene signaling modulators
  • v
  • t
  • e
TRP channel modulators
TRPA
Activators
  • 4-Hydroxynonenal
  • 4-Oxo-2-nonenal
  • 5,6-EET
  • 12S-HpETE
  • 15-Deoxy-Δ12,14-prostaglandin J2
  • α-Sanshool (ginger, Sichuan and melegueta peppers)
  • Acrolein
  • Allicin (garlic)
  • Allyl isothiocyanate (mustard, radish, horseradish, wasabi)
  • AM404
  • ASP-7663
  • Bradykinin
  • Cannabichromene (cannabis)
  • Cannabidiol (cannabis)
  • Cannabigerol (cannabis)
  • Cinnamaldehyde (cinnamon)
  • CR gas (dibenzoxazepine; DBO)
  • CS gas (2-chlorobenzal malononitrile)
  • Cuminaldehyde (cumin)
  • Curcumin (turmeric)
  • Dehydroligustilide (celery)
  • Diallyl disulfide
  • Dicentrine (Lindera spp.)
  • Farnesyl thiosalicylic acid
  • Formalin
  • Gingerols (ginger)
  • Hepoxilin A3
  • Hepoxilin B3
  • Hydrogen peroxide
  • Icilin
  • Isothiocyanate
  • JT-010
  • Ligustilide (celery, Angelica acutiloba)
  • Linalool (Sichuan pepper, thyme)
  • Methylglyoxal
  • Methyl salicylate (wintergreen)
  • N-Methylmaleimide
  • Nicotine (tobacco)
  • Oleocanthal (olive oil)
  • Paclitaxel (Pacific yew)
  • PF-4840154
  • Phenacyl chloride
  • Polygodial (Dorrigo pepper)
  • Shogaols (ginger, Sichuan and melegueta peppers)
  • Tear gases
  • Tetrahydrocannabinol (cannabis)
  • Tetrahydrocannabiorcol
  • Thiopropanal S-oxide (onion)
  • Umbellulone (Umbellularia californica)
  • WIN 55,212-2
Blockers
  • A-967079
  • AM-0902
  • Dehydroligustilide (celery)
  • HC-030031
  • Nicotine (tobacco)
  • PF-04745637
  • Ruthenium red
TRPC
Activators
  • Adhyperforin (St John's wort)
  • Diacyl glycerol
  • GSK1702934A
  • Hyperforin (St John's wort)
  • Substance P
Blockers
  • DCDPC
  • DHEA-S
  • Flufenamic acid
  • GSK417651A
  • GSK2293017A
  • Meclofenamic acid
  • N-(p-Amylcinnamoyl)anthranilic acid
  • Niflumic acid
  • Pregnenolone sulfate
  • Progesterone
  • Pyr3
  • Tolfenamic acid
TRPM
Activators
  • ADP-ribose
  • BCTC
  • Calcium (intracellular)
  • CIM-0216
  • Cold
  • Coolact P
  • Cooling Agent 10
  • Eucalyptol (eucalyptus)
  • Frescolat MGA
  • Frescolat ML
  • Geraniol
  • Hydroxycitronellal
  • Icilin
  • Linalool
  • Menthol (mint)
  • PMD 38
  • Pregnenolone sulfate
  • Rutamarin (Ruta graveolens)
  • Steviol glycosides (e.g., stevioside) (Stevia rebaudiana)
  • Sweet tastants (e.g., glucose, fructose, sucrose; indirectly)
  • Thio-BCTC
  • WS-12
Blockers
  • AMG-333
  • Capsazepine
  • Clotrimazole
  • DCDPC
  • Elismetrep
  • Flufenamic acid
  • Meclofenamic acid
  • Mefenamic acid
  • N-(p-Amylcinnamoyl)anthranilic acid
  • Nicotine (tobacco)
  • Niflumic acid
  • Ononetin
  • PF-05105679
  • RQ-00203078
  • Ruthenium red
  • Rutamarin (Ruta graveolens)
  • Tolfenamic acid
  • TPPO
  • TRPM4-IN-5
TRPML
Activators
  • EVP21
  • MK6-83
  • ML-SA1
  • ML2-SA1
  • PI(3,5)P2
  • SF-22
  • SN-2
Blockers
  • ML-SI3
  • PI(4,5)P2
TRPP
Activators
  • Triptolide (Tripterygium wilfordii)
Blockers
  • Ruthenium red
TRPV
Activators
  • 2-APB
  • 5,6-EET
  • 9-HODE
  • 9-oxoODE
  • 12S-HETE
  • 12S-HpETE
  • 13-HODE
  • 13-oxoODE
  • 20-HETE
  • α-Sanshool (ginger, Sichuan and melegueta peppers)
  • Allicin (garlic)
  • AM404
  • Anandamide
  • Bisandrographolide (Andrographis paniculata)
  • Camphor (camphor laurel, rosemary, camphorweed, African blue basil, camphor basil)
  • Cannabidiol (cannabis)
  • Cannabidivarin (cannabis)
  • Capsaicin (chili pepper)
  • Carvacrol (oregano, thyme, pepperwort, wild bergamot, others)
  • DHEA
  • Diacyl glycerol
  • Dihydrocapsaicin (chili pepper)
  • Estradiol
  • Eugenol (basil, clove)
  • Evodiamine (Euodia ruticarpa)
  • Gingerols (ginger)
  • GSK1016790A
  • Heat
  • Hepoxilin A3
  • Hepoxilin B3
  • Homocapsaicin (chili pepper)
  • Homodihydrocapsaicin (chili pepper)
  • Incensole (incense)
  • Lysophosphatidic acid
  • Low pH (acidic conditions)
  • Menthol (mint)
  • N-Arachidonoyl dopamine
  • N-Oleoyldopamine
  • N-Oleoylethanolamide
  • Nonivamide (PAVA) (PAVA spray)
  • Nordihydrocapsaicin (chili pepper)
  • Paclitaxel (Pacific yew)
  • Paracetamol (acetaminophen)
  • Phenylacetylrinvanil
  • Phorbol esters (e.g., 4α-PDD)
  • Piperine (black pepper, long pepper)
  • Polygodial (Dorrigo pepper)
  • Probenecid
  • Protons
  • RhTx
  • Rutamarin (Ruta graveolens)
  • Resiniferatoxin (RTX) (Euphorbia resinifera/pooissonii)
  • Shogaols (ginger, Sichuan and melegueta peppers)
  • Tetrahydrocannabivarin (cannabis)
  • Thymol (thyme, oregano)
  • Tinyatoxin (Euphorbia resinifera/pooissonii)
  • Tramadol
  • Vanillin (vanilla)
  • Zucapsaicin
Blockers
  • α-Spinasterol (Vernonia tweediana)
  • AMG-517
  • AMG-9810
  • Asivatrep
  • BCTC
  • Cannabigerol (cannabis)
  • Cannabigerolic acid (cannabis)
  • Cannabigerovarin (cannabis)
  • Cannabinol (cannabis)
  • Capsazepine
  • DCDPC
  • DHEA
  • DHEA-S
  • Flufenamic acid
  • GRC-6211
  • HC-067047
  • Lanthanum
  • Mavatrep
  • Meclofenamic acid
  • N-(p-Amylcinnamoyl)anthranilic acid
  • NGD-8243
  • Niflumic acid
  • Pregnenolone sulfate
  • RN-1734
  • RN-9893
  • Ruthenium red
  • SB-366791
  • SB-705498
  • Tivanisiran
  • Tolfenamic acid
  • TRPV3-74a
See also: Receptor/signaling modulators • Ion channel modulators
Retrieved from "https://teknopedia.ac.id/w/index.php?title=Curcumin&oldid=1333126803"
Categories:
  • Curcuminoids
  • CYP2B6 inhibitors
  • CYP2D6 inhibitors
  • E-number additives
  • Experimental medical treatments
  • Food colorings
  • Histone deacetylase inhibitors
  • Plant dyes
Hidden categories:
  • PubChem ID (CID) same as Wikidata
  • CS1 French-language sources (fr)
  • CS1 German-language sources (de)
  • Articles with short description
  • Short description is different from Wikidata
  • Use American English from July 2021
  • All Wikipedia articles written in American English
  • Articles with changed EBI identifier
  • ECHA InfoCard ID from Wikidata
  • E number from Wikidata
  • Articles containing unverified chemical infoboxes
  • Articles containing potentially dated statements from July 2021
  • All articles containing potentially dated statements

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id